We report on direct time-of-flight based mass measurements of 16 light neutron-rich nuclei. These include the first determination of the masses of the Borromean drip-line nuclei (19)B, (22)C, and (29)F as well as that of (34)Na. In addition, the most precise determinations to date for (23)N and (31)Ne are reported. Coupled with recent interaction cross-section measurements, the present results support the occurrence of a two-neutron halo in (22)C, with a dominant ν2s(1/2)(2) configuration, and a single-neutron halo in (31)Ne with the valence neutron occupying predominantly the 2p(3/2) orbital. Despite a very low two-neutron separation energy the development of a halo in (19)B is hindered by the 1d(5/2)(2) character of the valence neutrons.
International audienceMeasurements and ion optic calculations showed that the large momentum acceptance of the VAMOS spectrometer at GANIL could be further increased from $\sim$ 11% to $\sim$ 30% by suitably enlarging the dimensions of the detectors used at the focal plane. Such a new detection system built for the focal plane of VAMOS is described. It consists of larger area detectors (1000 mm × 150 mm) namely, a Multi-Wire Parallel Plate Avalanche Counter (MWPPAC), two drift chambers, a segmented ionization chamber and an array of Si detectors. Compared to the earlier existing system (VAMOS), we show that the new system (VAMOS++) has a dispersion-independent momentum acceptance . Additionally a start detector (MWPPAC) has been introduced near the target to further improve the mass resolution to $\sim$ 1/220. The performance of the VAMOS++ spectrometer is demonstrated using measurements of residues formed in the collisions of 129Xe at 967 MeV on 197Au
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.